Mpumalanga – When 24-year-old Gabisile Zulu discovered she was pregnant she was thrilled. Her joy was short lived because she was also diagnosed with tuberculosis – she was now fighting two diseases, HIV and TB.
At a recent international TB conference, some doctors suggested countries with weak health systems should not be allowed to use new TB drugs, although the old ones are ineffectual and cause deafness. Thankfully, South Africa is leading the world in treating drug-resistant TB.
One week, two UN high level meetings on health matters – and virtually no interaction between the two. But diabetes, cancer and depression have a major impact on tuberculosis. If we treat them in silos, we won’t overcome them. HEALTH-E NEWS’ Amy Green.
Civil society groups have criticised the United Nations declaration on tuberculosis (TB) ratified yesterday (26 Sept) saying it ‘falls short’ on critical issues in the fight against the world’s top infectious killer.
Brazil, Russia, India, China and South Africa account for half of the world’s tuberculosis cases, but only South Africa’s president will attend today’s (September 26th) first United Nations high-level meeting on TB.
Last week the World Health Organsiation (WHO) changed its treatment recommendations for the deadliest form of TB, drug-resistant tuberculosis (DR-TB), following South Africa’s bold decision.
South Africa made history on Monday when the health department announced that all drug-resistant tuberculosis (DR-TB) patients will be eligible to receive the new medicine, bedaquiline, becoming the first country to do so.
A death sentence. That is how the deadliest form of tuberculosis (TB) is often described. But breakthrough data from South Africa on the blockbuster anti-TB drug bedaquiline could change the fate of people with extensively drug-resistant TB (XDR-TB).